DSC
GWPH

Duncker Streett & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Duncker Streett & Co’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$34K – 545
2019
Q2 		$34K Hold
200
– – 0.01% 399
2019
Q1 		$34K Buy
+200
New +$29.8K 0.01% 407

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Duncker Streett & Co's GWPH Position: Q3 2019 in Review

Duncker Streett & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 200 shares — an estimated $34K sold.

Duncker Streett & Co first reported a position in GWPH in Q1 2019 and held it in 2 quarters. The position peaked at $34K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Duncker Streett & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Duncker Streett & Co sold 200 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $34K.
  • Duncker Streett & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
  • Duncker Streett & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $34K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Duncker Streett & Co's 13F filing for Q3 2019, filed 31 Oct 2019.